Overview

Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply

Status:
Active, not recruiting
Trial end date:
2021-04-30
Target enrollment:
Participant gender:
Summary
This is a Phase 2 single arm study to investigate efficacy and safety of P1101 for adult Japanese patients with PV.
Phase:
Phase 2
Details
Lead Sponsor:
PharmaEssentia Japan K.K.
Treatments:
Aspirin